FGF2, an Immunomodulatory Factor in Asthma and Chronic Obstructive Pulmonary Disease (COPD)
The fibroblast growth factor 2 (FGF2) is a potent mitogenic factor belonging to the FGF family. It plays a role in airway remodeling associated with chronic inflammatory airway diseases, including asthma and chronic obstructive pulmonary disease (COPD). Recently, research interest has been raised in...
Main Authors: | Yuanyang Tan, Yongkang Qiao, Zhuanggui Chen, Jing Liu, Yanrong Guo, Thai Tran, Kai Sen Tan, De-Yun Wang, Yan Yan |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-04-01
|
Series: | Frontiers in Cell and Developmental Biology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fcell.2020.00223/full |
Similar Items
-
Airflow obstruction: is it asthma or is it COPD?
by: Rogliani P, et al.
Published: (2016-11-01) -
Use of capnography for prediction of obstruction severity in non-intubated COPD and asthma patients
by: Barak Pertzov, et al.
Published: (2021-05-01) -
Abnormal ADAM17 expression causes airway fibrosis in chronic obstructive asthma
by: Jing-Yun Chen, et al.
Published: (2021-08-01) -
A Belgian survey on the diagnosis of asthma–COPD overlap syndrome
by: Cataldo D, et al.
Published: (2017-02-01) -
Asthma and Obstructive Sleep Apnea
by: Yi-Xian Qiao, et al.
Published: (2015-01-01)